This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

Regulatory Frameworks

Legal updates to keep you informed and in touch with the latest regulatory industry news

INSIGHTS FROM THE EU COMMISSION AND INDUSTRY COUNSEL

Stay in touch with the need-to-know updates direct from the EU Commissions and industry.


Take a look at some of the talks covered below:

New Developments on Availability and Shortage of Medicine Across Europe
  • Availability challenges and shortage of medicines
  • New developments, legislation and policies to address shortage of medicines
  • How will developments affect industry practice and how should the industry respond?

Kristine Peers, General Counsel, EPFIA

Affordability of Medicines, Price Transparency and Market Access
  • The WHO Draft resolution “Improving the transparency of markets for medicines, vaccines and other health products”
  • National levers being employed to drive competition and encourage transparency

Carlo Simone Massenti, Vice President Legal Italy and Western & Southern Europe, AstraZeneca

Arianna Greco, Vice President, Head of International Legal, Alnylam Pharmaceuticals

Sophie Pele, Partner, Dechert LLP

Claus Kastberg Nielsen, Partner, Managing Director, Copenhagen Economics

Legal Considerations Regarding the Use of Unapproved Products
  • Rise in the use of the “compassionate use” mechanism
  • Examining compounding and the Hospital Exemption
  • Recent developments regarding off-label and unapproved products
  • Legal challenges and the wider implications for industry

Hilary Jones, Senior Director, Legal, Gilead Sciences

Catherine Longeval, Partner, Van Bael & Bellis LLP

EU Commission Update on the Regulatory Landscape
  • The new European Commission 2019-2024: areas of focus for potential legislative revision
  • Update on the review into pharmaceutical incentives and rewards: views and timetable
  • Environmental aspects of medicines: to what extent will the industry be subjected to new environmental requirement

Florian Schmidt, Deputy Head of Unit, DG SANTE, European Commission 

The Regulatory Frameworks 2019 List

Join peers and clients from around the globe at the EU Pharmaceutical Law Forum.
You will meet the likes of:

  • Advokatfirman Delphi
  • Advokatfirman Hammarskiold & Co
  • AL Goodbody Solicitors
  • Alkaloid AD Skopje
  • Allen & Overy LLP
  • Apollegis
  • Arnold & Porter Kaye Scholer
  • Arthur Cox Unlimited Company
  • AstraZeneca spa
  • Bar and Karrer AG
  • Bausch & Lomb UK Limited
  • Bech-Bruun Law Firm
  • ByrneWallace
  • Clifford Chance
  • CMS
  • Copenhagen Economics
  • Dabias
  • DADA Consultancy BV
  • DLA Piper
  • Fieldfisher Jausas
  • Firat Izgi Attorney Partnership
  • Gedeon Richter Plc
  • Gianni Origoni Grippo Cappelli Partners
  • Gomez-Acebo and Pombo Abogados SLP
  • Gun and Partners
  • GW Pharmaceuticals
  • H Lundbeck AS
  • Hammarskiold and Co.
  • HGF Limited
  • Hogan Lovells International LLP
  • Hoyng Rokh Monegier LLP
  • Johnson and Johnson
  • K S Partners
  • Kasznar Leonardos Intellectual Property
  • Kromann Reumert
  • Kyowa Kirin International Plc
  • Leijnse Artz
  • Mannheimer Swartling Advokatbyra AB
  • Merck Sharp & Dohme Limited
  • Mundipharma International
  • NautaDutilh
  • NOVACOS Rechtsanwalte Partnerschaft mbB
  • Novartis Pharma AG
  • NovoNordisk
  • NSN Law Firm
  • Plesner
  • Portolano Cavallo
  • Preu Bohlig and Partner
  • RP Law Firm
  • Samsung Bioepis
  • Seqirus
  • Sidley Austin LLP
  • Sociedade Rebelo de Sousa
  • Stibbe
  • Studio Legale Russo Valentini
  • Swedish Orphan Biovitrum AB (publ)
  • Taylor Wessing
  • TESARO Bio GmbH
  • Teva Pharmaceuticals
  • UCB
  • Uria Menendez Abogados SLP
  • Vieira de Almeida & Associados
  • Vondst Advocaten N.V.
  • Westerberg and Partners